|

MEN2501 Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Pipeline

Phase 1: 1

Top Sponsors

  • Stemline Therapeutics, Inc.1

Indications

  • Platinum-resistant Ovarian Cancer1
  • Cancer1

Springdale, Arkansas1 trial

A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

Highlands Oncology Group

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.